Sleep disordered breathing (SDB) and hypertension are commonly associated. In this study, we assessed how longitudinal measures of SDB predict a 24-h ambulatory blood pressure monitoring (ABPM) profile. Participants (n ϭ 82) were recruited from a community-based urban (26% African American) sample and included family members of patients with laboratory diagnosed SDB (cases) and family members of neighborhood control subjects evaluated at baseline and at 5 years. Nearly all participants were normotensive and were not receiving therapy for SDB. During both examinations, the respiratory distress index (RDI) was assessed with overnight in-home polysomnography. Seated blood pressure (BP) was assessed at a baseline examination (t 1 ) and after a 5-year follow-up period (t 5 ), when 24-h ABPM also was performed.
H
ypertension occurs in 34% of the US population, and the cause is unknown in Ͼ90% of those affected. Sleep disordered breathing (SDB) and hypertension are commonly associated. 1 As many as 80% of unselected hypertensives have SDB, with the cooccurrence of these conditions especially notable in elderly populations. [2] [3] [4] Both disorders are associated with an increase in cardiovascular disease (CVD), target organ damage, clinical CVD events, and mortality. 5 The increased CVD risk with SDB may be due to the blood pressure (BP) elevation; however, other markers of cardiovascular risk, eg, decreased heart rate variability (RR variability by spectral analysis), 6 increased platelet aggregation, 7 and increased left ventricular hypertrophy (in dialysis patients) 8 have also been associated in subjects with SDB. Several studies have suggested that SDB may be a secondary cause of hypertension and that treatment of SDB may ameliorate hypertension. However, daytime office readings may underestimate BP load in SDB patients. 9, 10 Additionally, the nondipper status in some hypertensive subjects evaluated by 24-h ambulatory blood pressure monitoring (ABPM) may be explained, at least in part, by BP elevation during nocturnal apneic episodes. 11, 12 Proving the link between SDB, human hypertension, and its sequellae has been complicated by several limitations of the available data. The studies to date have gen-erally been cross-sectional, have been of short duration, or have examined the effects of SDB therapy on BP rather than prospectively evaluating the long-term effects of the SDB on BP and its consequences. Additionally, the extent to which this relationship is independent of potential confounders (eg, obesity, ethnicity, comorbidities) remains controversial and inadequately studied. Finally, few studies of SDB have had significant representation of minority subgroups.
In this study, we specifically assessed how longitudinal measures of SDB predict 24-h ABPM profile. We used two measures of SDB (respiratory distress index [RDI] and O 2 saturation nadir) performed over a 5-year interval to permit a better assessment of "exposure" (to SDB). They also allowed us to assess whether patterns of change in apneic activity predict BP level. Additionally, the use of 24-h ABPM allowed us to further minimize measurement error of our dependent variable and permitted us to explore the state (sleep/wake) dependency of BP patterns. Finally, examination of a population free of antihypertensive and other confounding medications minimized potential drug-related misclassifications. Thus, the objectives of the study were to define, in a community-based urban sample, the relationship between change in apneic activity over time and 24-h ABPM, and to assess the significance of confounders (eg, age, ethnicity, and obesity on BP in this sample).
Methods
This study consisted of a nested study within a larger longitudinal, community-based cohort study that was designed to evaluate CVD risk associated with SDB. Participants (n ϭ 82) consisted of family members of patients with laboratory diagnosed SDB (cases) and family members of neighborhood control subjects. Inclusion criteria for the substudy included age 25 to 60 years, a RDI Ͻ 50, no treatment for sleep apnea (eg, continuous positive airway pressure), body mass index (BMI) Յ 34, and no use of antihypertensive, sedative, or hypnotic medications at baseline or follow-up examinations.
Study Procedures
All participants were evaluated at a baseline (t 1 ) and at 5-year follow-up examination (t 5 ). During both examinations, SDB was assessed with overnight in-home monitoring of airflow, heart rate, chest wall impedance, and oximetry using the Edentec I or II (Mallinkrodt, Minneapolis, MN). These machines record nasal/oral airflow, finger pulse oximetry, heart rate, chest wall impedance, snoring, and position. The RDI (apneas and hypopneas Ն 10 sec with Ն 2.5% reductions in oxygen saturation)/estimated sleep time [h] ) was assessed at baseline and 5 years later. The RDI determined with this system has been found to correlate highly with the RDI from in-laboratory polysomnography (r Ͼ 0.96). 13 Random home seated BP measurements were measured in duplicate at each examination using calibrated aneroid or mercury sphygmomanometers according to standardized procedures.
14 Twenty-four-hour ABPM, assessed with Spacelabs 90207 (Redmond, WA), was incorporated into the 5-year examination but was not evaluated at baseline. Blood pressures were measured at 30-min intervals during the day and night. Cuffs appropriate for arm circumference were used, and the units were calibrated based on standardized procedures. 15 Participants were asked to complete a diary to determine activities, bedtime, awakenings, and medication ingestion. Those ABPM sessions that failed to produce at least one valid BP per hour for 24 h were repeated. All data were retrieved the following day, printed at the laboratory, and stored digitally. Body mass index (kg/m 2 ) was determined at each visit by direct measurements. Data related to smoking and alcohol use were obtained from standardized questionnaires. 16 
Statistical Analysis
Nondipper status was defined as a Ͻ10% decrease in average mean arterial pressure (MAP) during sleep compared to MAP while awake. Smoking status was defined as "current" if the subject reported smoking at least one cigarette/day in the last month. Alcohol use was based on self-reported ingestion of beer, liquor, or wine on most days over the last month. The independent variables considered were the averages and the difference in the two RDI measured at baseline (t 1 ) and follow-up (t 5 ), as well as oxygen saturation nadirs from the two sleep studies. The average and difference in RDI were used because each is uncorrelated with the other and, together, they provide indices of "average exposure" and "change in exposure."
Correlations among variables were assessed with Spearman correlation coefficients. In multiple regression analyses, 24-h, maximal, awake, and sleep average BP values from the ABPM were considered to be the dependent variables. Potential confounders entered into the models included age, gender, race, alcohol and smoking status, and BMI. Backward stepwise regression was used to identify covariates that predicted the BP outcomes at a P value Ͻ .10. Subsequently, multiple regression was used (Proc Reg, SAS PC 6.1, SAS, Cary, NC) to build the final models.
Results
A description of the sample at baseline (t 1 ) and on follow-up approximately 5 years later (t 5 ) is provided in Table 1 . Approximately half of the sample were female and 26% were African American. In this sample (n ϭ 82), 45 subjects were recruited as members of families with a known case of laboratory-confirmed SDB (index families); the remainder were recruited from neighborhood control families. Both at baseline and at follow-up, the group mean daytime (casual) BP values were normal, and neither the casual SBP nor DBP changed significantly over the 5-year interval. Although those with a history of previous antihypertensive therapy or diagnosis of hypertension were excluded, one individual had an SBP Ͼ 140 mm Hg at both baseline and follow-up visits, and another had a DBP Ͼ 90 mm Hg at both visits (although neither was previously known to be hypertensive). Excluding the results in these subjects did not alter the findings of the study.
At baseline, 40% of the sample had at least mild SDB (RDI Ͼ 5 events/h), and 13% had values of SDB of moderate severity (RDI 15 to 38 events/h). Over the 5 years, the average RDI increased from 6.6 Ϯ 7.4 (range 0 to 38.5) to 9.0 Ϯ 8.3 (range 0.1 to 33.9), and the average oxygen saturation nadir during sleep decreased slightly to 88.8% Ϯ 4.7% (range 68% to 96%). At follow-up, the proportion of the sample with mild to moderate SDB increased to 59%, and the proportion with moderate SDB increased to 17%.
The subjects in the highest quartile for change in RDI over 5 years (change in RDI Ͼ 6.7) were similar in regard to gender, age, and ethnicity to those with less progression of SDB (data not shown). However, those with the largest increases in RDI experienced the largest increase in BMI (3.12 Ϯ 3.26 kg/m 2 v 0.4 Ϯ 2.70 kg/m 2 ; P ϭ .002). The BMI in these subjects was significantly higher at both baseline (31. Abbreviations as in Table 1 .
P ϭ .008) than in subjects with less progression of RDI. The Spearman correlations showed no significant relationships of age with BMI, average or change in RDI, and any BP measure. Also, no associations were observed between BMI (at baseline, follow-up, or change) and any BP reading other than for a relationship between change in BMI and 24-h diastolic maximum pressure (r ϭ 0.22, P Ͻ .05). Baseline BMI (t 1 ) was significantly associated with a mean RDI (r ϭ 0.25, P ϭ .02), and BMI at (t 5 ) was associated with a change in RDI (r ϭ 0.21, P Ͻ .05). No significant associations of mean RDI with BP variables measured over the 24-h period was noted in univariate analyses. In contrast, a change in RDI was significantly associated with 24-h mean SBP, 24-h maximum DBP, sleep mean SBP and mean DBP, and sleep maximum SBP ( Table 2) . The results of multiple regression analyses, predicting each of the 24-h BP outcomes as a function of the SDB variables (mean RDI, change in RDI, and mean saturation nadir), and possible confounders (age, ethnicity, gender, BMI, change in BMI, current smoking status, and current alcohol consumption) are shown in Table 3 . Average 24-h MAP and mean 24-h DBP were each best predicted by change in RDI (t 5 Ϫt 1 ), explaining 3% to 4% of the variance in these 24-h BP readings, and by current smoking status. After accounting for these variables, BP was not predicted by any of the other potential confounders (all P Ͼ .10). The 24-h mean SBP was best predicted by male gender and change in BMI. After accounting for these variables, mean oxygen saturation nadir (t 1 , t 5 ) was marginally associated with this parameter (P ϭ .10). Maximum 24-h SBP was predicted by average RDI over the 5-year follow-up and change in BMI over this interval. Maximum DBP reading was associated with male gender, African American ethnicity, change in BMI, and alcohol use, but with none of the SDB parameters (Table 3) .
Similar analyses were performed for BP values summarized across sleep and wakefulness. During sleep, the mean arterial, mean systolic, and maximum SBP were each predicted by mean RDI over the 5-year follow-up period (accounting for 6% to 8% of the variance in these sleep-specific BP measures) ( Table 4) . Diastolic pressures during sleep, however, were not predicted by the SDB variables. Regression models for BP values measured during wakefulness generally followed the pattern observed for overall 24-h readings, with the slight exception that the relationship between average RDI and systolic maximum pressures was significant for models based on the daytime maximum SBP (P ϭ .02) although only marginally (P ϭ .06) for models predicting maximum SBP over 24 h.
At the 5-year ABPM, 22 subjects (27%) were classified as nondippers by ABPM (Table 1) . A greater proportion of subjects with a baseline RDI Ͼ 15/h met the nondipper definition at follow-up compared to subjects with an RDI Յ 15 h (64% v 21%, respectively; P ϭ .003) ( Table  5 ). However, no relationship was seen between RDI levels at follow-up and "dipping" status, nor between ethnicity or sex and dipping status. Tables 1 and 2 . * Based on multiple stepwise (backward) regression analysis, including age, ethnicity, gender, body mass index (at t 5 and change t 5 -t 1 ), average oxygen saturation nadir, average RDI, change in RDI (t 5 -t 1 ) current smoking, current alcohol use.
Discussion
In this longitudinal study of a community-based urban sample, we found a significant relationship between SDB parameters and increased BP on 24-h ABPM. The study sample was largely normotensive and included a sizable proportion (26%) of African Americans. In this largely normotensive sample, mean casual BP did not change over the 5 years of follow-up. In contrast, RDI levels did increase by approximately 30%. However, it should be noted that although we recruited from a population with an increased prevalence of SDB, only 13% of our sample had an RDI Ͼ 15 at baseline. Thus, the associations observed for 24-h BP readings in individuals who would be classified as normotensive, over a relatively modest range of RDI, may underestimate effects in individuals with greater levels of risk. However, data from such a sample does provide an indication of potential exposure-response relationships that are not confounded by medication use or comorbid conditions.
A key finding of this study was that change in RDI over the follow-up period was significantly correlated with 24-h MAP and 24-h maximum and mean sleep DBP. In addition, sleep MAP and SBP were predicted by the mean of baseline and 5-year follow-up RDI. Because these subjects were normotensive and were prescreened for medications, potential confounding due to medications or disease were minimized.
The findings in this study complement the results of two large epidemiologic studies that have recently become available. 17, 18 In the Sleep Heart Health Study, the odds ratio for hypertension was determined in a cross-sectional survey of Ͼ6400 participants, aged Ͼ 40 years, without diagnosed sleep apnea, and recruited from ongoing cohort studies of cardiovascular and respiratory disease. This study reported an odds ratio for hypertension of 1.37 in those with an RDI Ͼ 30 compared to those with an RDI Ͻ 1.5 and an odds ratio of 1.46 if comparing percentage of time above and below 90% saturation. 18 The second study was the first large-scale longitudinal study of cardiovascular consequences of SDB in 709 subjects, and demonstrated the first temporal relationship between SDB measured at baseline and subsequent risk of hypertension. 17 The present study, also a longitudinal study, confirms and extends these findings. Whereas 28% of the participants in the former study already had stage 1 or greater hypertension, 17 we report the association between SDB parameters and BP over time in a normotensive sample. Even in this smaller study sample, we report, for the first time, a significant direct correlation between 24-h mean and sleep BP levels with longitudinally determined measures of RDI over time.
The association between SDB and elevated BP has been consistently reported over the last 25 years, although the previously noted limitations of these studies prevented definitive interpretation of this relationship. Blood pressure elevation with SDB has been linked to increased sympathetic activity as evidenced by increased norepinephrine in urine and plasma, and increased renal and muscle sympathetic activity on nerve recording, which decreases with CPAP in the case of the latter. 19 -22 Increased angiotensin II 23 and endothelin levels have also been reported. 24 Some studies have suggested that sleep fragmentation, in addition to hypoxia, may contribute to the increased sympathetic activity and BP elevation. However, this has not been a consistent finding. 25, 26 Compensatory increases in endogenous vasodilators such as atrial natriuretic peptide 27 and prostanoids have been reported in response to these vasoconstrictor stimuli. 28 Whether these mechanisms are operating in this study population or influence long-term BP control remains unclear. In addition, it remains to be established whether the BP changes seen in this normotensive sample translate into the high incidence of hypertension and its complications in patients with SDB.
In summary, this study for the first time documents the association between changes in sleep apnea activity over time and 24-h BP profile. These associations were noted in a community-based normotensive sample. The strongest associations were between multiple 24-h BP parameters and change in RDI over the period. This suggests that individuals with progressive SDB may be especially vulnerable to adverse hemodynamic responses, including those associated with elevated BP. Whether this is related to the pressor effects of changing nocturnal exposures to hypoxia or sympathetic activation, or whether "progressive SDB" may be a marker for an underlying vulnerability to hypertension and CVD, is unclear. Further long-term evaluation of the effects of these findings and their longterm consequences are desperately needed.
